- Transurethral resection of the prostate (TURP) is superior to prostatic artery embolization (PAE) for the treatment of benign prostatic hyperplasia (BPH).
Why this matters
- There are no standards or guidelines for evaluating the clinical efficacy of TURP and PAE for treating BPH.
- Researchers analyzed 4 studies comparing the efficiency and safety of TURP with that of PAE (N=506).
- Funding: None disclosed.
- Pooled data showed that peak urinary flow rate was significantly higher in patients who underwent TURP vs those who underwent PAE:
- Weight mean difference (WMD), 4.66 (95% CI, 2.54-6.79; P<.05>
- Postoperative QoL was lower for TURP than PAE:
- WMD, −0.53 (95% CI, −0.88 to −0.18; P<.05>
- Postoperative prostate volume was significantly smaller for TURP than PAE:
- WMD, −8.26 (95% CI, −12.64 to −3.88; P<.05>
- Operative time was significantly shorter for TURP than PAE:
- WMD: −10.55 (95% CI, −16.92 to −4.18; P=.001).
- Only 2 studies were randomized controlled trials.
- Studies had small sample sizes and short follow-up periods that may have contributed to worse outcomes for PAE.